Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Affymetrix, Inc.    AFFX

Delayed Quote. Delayed  - 03/31 10:00:00 pm
14.01 USD   +0.14%
04/05 AFFYMETRIX : Receives a Hold from Cantor Fitzgerald (Cantor Bryan Br..
04/01 AFFYMETRIX : Grant Supports Outcomes Research for Noninvasive Genomi..
03/31DJTHERMO FISHER S : Completes Acquisition of Affymetrix
SummaryQuotesChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 

Affymetrix, Inc. : Affymetrix to Host Conference Call on May 3, 2012 to Announce First Quarter 2012 Operating Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/17/2012 | 10:20pm CEST

Affymetrix, Inc. (NASDAQ: AFFX) today announced that its first quarter 2012 operating results will be reported after market close on Thursday May 3, 2012. The company will also hold a conference call on the same day at 5:00pm ET.

A live webcast can be accessed by visiting the investor relations section of the company's website at www.affymetrix.com. Alternatively, investors and other interested parties may listen to the live conference call by dialing 877-407-8291 (domestic) or 201-689-8345 (international).

A replay of this call will be available from 5:00pm PT on May 3, 2012 until 8:00pm PT on May 10, 2012 at the following numbers: 877-660-6853 (domestic), 201-612-7415 (international). The conference identification number for the replay is 392482. An archived webcast of the conference call will be available under the investor relations section of the company's website at www.affymetrix.com.

About Affymetrix

Affymetrix technology is used by the world's top pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and nonprofit research institutes. More than 2,000 systems have been shipped globally and approximately 25,000 peer-reviewed papers have been published using the technology.

Affymetrix is headquartered in Santa Clara, Calif., and has manufacturing facilities in Santa Clara, Cleveland, Ohio, and Singapore. The company has about 900 employees worldwide and maintains sales and distribution operations across Europe, Asia, and Latin America. For more information about Affymetrix, please visit www.affymetrix.com.

Affymetrix, Inc.
Investor:
Doug Farrell, 408-731-5285
Vice President, Investor Relations


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AFFYMETRIX, INC.
04/05 AFFYMETRIX : Receives a Hold from Cantor Fitzgerald (Cantor Bryan Brokmeier Comm..
04/01 AFFYMETRIX : Grant Supports Outcomes Research for Noninvasive Genomic Profiling
03/31 AFFYMETRIX : Entry into a Material Definitive Agreement, Termination of a Materi..
03/31 AFFYMETRIX : Determines Unsolicited Proposal from Origin Technologies Could Lead..
03/31DJTHERMO FISHER SCIENTIFIC : Completes Acquisition of Affymetrix
03/31DJTHERMO FISHER SCIENTIFIC : Completes Acquisition of Affymetrix
03/31 AFFYMETRIX : Origin Significantly Enhances All-Cash Offer for Affymetrix
03/31 AFFYMETRIX : Former Affymetrix Senior Executives Propose to Acquire Affymetrix f..
03/30 AFFYMETRIX : Faruqi & Faruqi, LLP : Announces Filing of a Class Action Lawsuit A..
03/29 THERMO FISHER SCIENTIFIC : Affymetrix Reaffirms Support For Thermo Fisher Merger..
More news
Sector news : Bio Diagnostics & Testing
03:37pDJARROWHEAD PHARMACEUTICALS : Amgen, Arrowhead Pharma Agree to Cardiovascular Coll..
09/27DJAMGEN : Myeloma Treatment Study Fails to Meet Primary Endpoint
09/26DJSANOFI : FDA Accepts Sanofi's, Regeneron's Dermatitis Treatment for Priority Rev..
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
More sector news : Bio Diagnostics & Testing
News from SeekingAlpha
04/02 WEEK IN REVIEW : Deals Dominate China Biopharma News
03/31 IBM Buys Salesforce.com Cloud Consultant
03/30 30% Annual Return From This Stock
03/29 *Except For Amazon
03/29 WALL STREET BREAKFAST : Yellen Speech Takes Center Stage
Advertisement
Chart AFFYMETRIX, INC.
Duration : Period :
Affymetrix, Inc. Technical Analysis Chart | AFFX | US00826T1088 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Managers
NameTitle
Jami K. Dover Nachtsheim Chairman
Andrew J. Last Chief Operating Officer & Executive Vice President
Robert H. Trice Independent Director
Gary S. Guthart Independent Director
Merilee Raines Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AFFYMETRIX, INC.38.85%0
MIRACA HOLDINGS INC.-4.68%2 867
BEIJING STRONG BIOTECH..--.--%1 710
SEEGENE INC--.--%883
INNATE PHARMA-20.90%663
LION BIOTECHNOLOGIES I..2.98%465
More Results